Weight LossInvestigational · Research use only
Semaglutide
Ozempic, Wegovy
GLP-1 receptor agonist that slows gastric emptying, improves insulin sensitivity, and reduces appetite. Widely studied for obesity and type 2 diabetes.
Class
Weight Loss
Targets
Loading research profile
Evidence
2 linked resources
Related
Eloralintide · Tirzepatide
★ Recommended Supplier
Get Semaglutide
Sourced from Orbitrex Peptide. Third-party tested. COA available on request.
Buy Semaglutide — 15% OFF15% OFF off with codeMOLECULAR
[01]
Research overview
Benefits
- Significant sustained weight loss
- Improved glycemic control
- Reduced cardiovascular events
- Appetite suppression
Research side effects
- Research-use only; safety data in healthy humans is limited or absent.
- Nausea / GI upset
- Appetite suppression
- Diarrhea or constipation
Timing
Often studied with or before meals; protocols vary by compound.
Common research stacks
Semaglutide
AOD-9604
5-Amino-1MQ
Cagrilintide
[06]
Trusted research partners
Partnered vendors we've verified sell this compound. Links go straight to the product page — use a member code at checkout.
[05]
Studies & resources
Research reference only · Review source material independently · Not medical advice